Puma Biotechnology (PBYI) Other Non Operating Income (2011 - 2026)
Puma Biotechnology (PBYI) reported Other Non Operating Income of $9,000 for Q2 2026, down 97.8% from $410,000 a year earlier and down 93.1% from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) Other Non Operating Income (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Puma Biotechnology's Other Non Operating Income came in at $397,000, down 71.3% year-over-year; for FY2025, it came in at $1.03 million, up 19.1% from FY2024.
- Other Non Operating Income has a five-year compound annual growth rate of 22.9% (FY2020 to FY2025).
- By year, Other Non Operating Income came in at $862,000 in FY2024 (+13.6%), $759,000 in FY2023, -$28,000 in FY2022 and $292,000 in FY2021 (-20.4%).
- The Q2 2026 figure ranks as the lowest quarterly Other Non Operating Income since Q1 2023.
- Year over year, Other Non Operating Income has now declined in each of the last four quarters, with growth averaging 61.6% over the last eight quarters.
- The high point for year-over-year Other Non Operating Income in five years was Q3 2024 (growth of 368.9%); the low point was Q2 2026 (a decline of 97.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $130,000 (Q1 2026), $143,000 (Q4 2025) and $115,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Puma Biotechnology | 485.99 Mn | 98.62 Mn | 44.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9,000.00 |
| Mar 31, 2026 | 130,000.00 |
| Dec 31, 2025 | 143,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Mar 31, 2025 | 359,000.00 |
| Dec 31, 2024 | 268,000.00 |
| Sep 30, 2024 | 347,000.00 |
| Jun 30, 2024 | 156,000.00 |
| Mar 31, 2024 | 91,000.00 |
| Dec 31, 2023 | 641,000.00 |
| Sep 30, 2023 | 74,000.00 |
| Jun 30, 2023 | 86,000.00 |
| Mar 31, 2023 | -42,000.00 |
| Dec 31, 2022 | -204,000.00 |
| Sep 30, 2022 | 64,000.00 |
| Jun 30, 2022 | 62,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 119,000.00 |
| Sep 30, 2021 | 71,000.00 |
API Access
Puma Biotechnology Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();